Abatacept (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Abatacept" in Polish language version.

refsWebsite

Global rank Polish rank

4^th place

7^th place

2^nd place

6^th place

1^st place

5,225^th place

3,508^th place

68^th place

31^st place

low place

222^nd place

228^th place

bms.com

Orencia – Full Prescribing Information. Bristol-Myers Squibb Company na stronie packageinserts.bms.com, sierpień 2009. [dostęp 2010-09-09]. (ang.).

G.G. Teng, A.M. Turkiewicz, L.W. Moreland. Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis. „Expert Opin Biol Ther”. 5 (9), s. 1245–1254, 2005. DOI: 10.1517/14712598.5.9.1245. PMID: 16120053.
L. Lundquist. Abatacept: a novel therapy approved for the treatment of patients with rheumatoid arthritis. „Adv Ther”. 24 (2), s. 333–345, 2007. DOI: 10.1007/BF02849902. PMID: 17565924.
R. Westhovens, J.C. Cole, T. Li, M. Martin i inni. Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial. „Rheumatology”. 45 (10), s. 1238–1246, 2006. DOI: 10.1093/rheumatology/kel066. PMID: 16567357.
J.M. Kremer, M. Dougados, P. Emery, P. Durez i inni. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. „Arthritis Rheum”. 52 (8), s. 2263–2271, 2005. DOI: 10.1002/art.21201. PMID: 16052582.
N. Ruperto, D.J. Lovell, P. Quartier, E. Paz i inni. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. „Lancet”. 372 (9636), s. 383–391, 2008. DOI: 10.1016/S0140-6736(08)60998-8. PMID: 18632147.

G.G. Teng, A.M. Turkiewicz, L.W. Moreland. Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis. „Expert Opin Biol Ther”. 5 (9), s. 1245–1254, 2005. DOI: 10.1517/14712598.5.9.1245. PMID: 16120053.
L. Lundquist. Abatacept: a novel therapy approved for the treatment of patients with rheumatoid arthritis. „Adv Ther”. 24 (2), s. 333–345, 2007. DOI: 10.1007/BF02849902. PMID: 17565924.
R. Westhovens, J.C. Cole, T. Li, M. Martin i inni. Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial. „Rheumatology”. 45 (10), s. 1238–1246, 2006. DOI: 10.1093/rheumatology/kel066. PMID: 16567357.
P.S. Hervey, S.J. Keam. Abatacept. „BioDrugs”. 20 (1), s. 53–61, 2006. PMID: 16573350.
J.M. Kremer, M. Dougados, P. Emery, P. Durez i inni. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. „Arthritis Rheum”. 52 (8), s. 2263–2271, 2005. DOI: 10.1002/art.21201. PMID: 16052582.
N. Ruperto, D.J. Lovell, P. Quartier, E. Paz i inni. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. „Lancet”. 372 (9636), s. 383–391, 2008. DOI: 10.1016/S0140-6736(08)60998-8. PMID: 18632147.